Statement Of Comprehensive Income [Abstract]

OSE Immunotherapeutics - Filing #2813125

Concept	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31
Statement of comprehensive income [abstract]
Profit (loss)	—	—	17 760 EUR	—	—	17 760 EUR	16 850 EUR	—	—	—	—	16 850 EUR
Other comprehensive income [abstract]
Components of other comprehensive income that will not be reclassified to profit or loss, net of tax [abstract]
Other comprehensive income, net of tax, gains (losses) on remeasurements of defined benefit plans	—	—	122,000 EUR	—	—	122,000 EUR	25,000 EUR	—	—	—	—	25,000 EUR
Components of other comprehensive income that will be reclassified to profit or loss, net of tax [abstract]
Exchange differences on translation [abstract]
Other comprehensive income, net of tax, exchange differences on translation of foreign operations	—	—	61,000 EUR	—	61,000 EUR	—	—	—	—	—	55,000 EUR	55,000 EUR
Other comprehensive income	—	—	61,000 EUR	—	—	—	—	—	—	—	—	29,000 EUR
Comprehensive income	0 EUR	0 EUR	17 699 EUR	0 EUR	61,000 EUR	17 638 EUR	16 825 EUR	0 EUR	0 EUR	0 EUR	55,000 EUR	16 879 EUR